Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBeijing Hospital of Traditional Chinese Medicine

About this trial

The investigators conducted a multicenter, prospective, randomized controlled clinical study to learn whether fire needling combined with filiform needling applied to pericranial muscle tenderness areas can effectively treat chronic migraine with comorbid tension-type headache. The study will also evaluate the safety and long-term efficacy of this therapy. Its main target questions include:

1. Can fire needling significantly reduce the number of headache days per month? 2. What is the effect of this therapy on headache intensity, emotional symptoms, and quality of life? The investigators will compare "fire needling at pericranial tender points plus conventional filiform needling" versus "conventional filiform needling alone" to verify whether the key technique of fire needling plus conventional filiform needling provides unique additive value.

Participants will:

1. Receive treatment twice per week for 8 weeks (either in the experimental group or the control group),attend a follow-up visit at week 24 after enrollment 2. Keep a headache diary (recording headache frequency, pain intensity, duration, associated symptoms, etc.) 3. Regularly complete assessments of emotional status, quality of life, and number of pericranial tender points

Eligibility criteria

Qualifiers

Meets the diagnostic criteria for tension-type headaches with pericranial tenderness;

Meets the diagnostic criteria for chronic migraine;

18 years ≤ age ≤ 65 years;

Has sufficient understanding to complete the necessary examinations and tests for the study;

Disqualifiers

Patients complicated with cluster headache or other primary headaches;

Patients with secondary headaches caused by intracranial space-occupying lesions, cranial infections, etc.;

Patients complicated with severe heart, liver or kidney impairment, coagulation disorders, infections, severe immunocompromise, or allergic predisposition;

Patients with alcohol or drug dependence;

Trial design

Treatments tested in this trial

  • filiform needling
  • fire needling combined with filiform needling

Treatment groups

88 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Beijing Hospital of Traditional Chinese Medicine

Lead sponsor

Capital's Funds for Health Improvement and Research

Collaborator